SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-10-000417
Filing Date
2010-01-05
Accepted
2010-01-05 14:26:29
Documents
1
Period of Report
2010-01-04

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 3400
  Complete submission text file 0001127602-10-000417.txt   5265
Mailing Address 41 PINELAWN ROAD MELVILLE NY 11747
Business Address 41 PINELAWN ROAD MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Issuer) CIK: 0000729922 (see all company filings)

IRS No.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O GENAISSANCE PHARMACEUTICALS INC FIVE SCIENCE PARK NEW HAVEN CT 06511
Business Address
KLEIN JOSEPH III (Reporting) CIK: 0001206369 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-15190 | Film No.: 10505919